News
Changes to Health Technology Assessment (HTA) in Europe offer new opportunities to streamline processes and get innovative ...
Greeks remain 'spectators' to pharmaceutical innovation. New medicines are frequently approved, but never reach patients.
Greeks remain 'spectators' to pharmaceutical innovation. New medicines are frequently approved, but never reach patients.
A recent study reveals that the average duration of ADHD medication for children and adolescents is more than three years. However, reliable, controlled data on the safety of marketed ADHD medicines ...
AI is increasingly being adopted by sponsors for various applications in clinical trials, including optimising trial design, ...
A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance Institution Kela reveals that the average duration of ADHD medication for children ...
Experts say the European Vulnerability Database, or EUVD, should be a good resource, but only if ENISA manages to maintain it properly.
The EU's General Court annulled on Wednesday a European Commission decision not to disclose text messages Commission ...
Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...
3d
Asianet Newsable on MSNMoleculin Biotech Gets EMA Nod For Leukemia Trial: Retail Feels Bullish On ‘Low And Slow’ SetupThe trial, which will involve sites in the U.S., Europe, and the Middle East, aims to combine Phase 2B and Phase 3 data for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results